|
#16
03.06.2010, 15:01
|
||||
|
||||
|
1) Telaprevir Achieves 75% Rate of Sustained HCV Response: Study
[Ссылки доступны только зарегистрированным пользователям ] 2)Hepatitis C Coinfection Increases Adverse Reactions to HAART [Ссылки доступны только зарегистрированным пользователям ] "HCV viremia seems to exacerbate adverse reactions, such as rash and hepatotoxicity, to nevirapine-based HAART," the authors conclude. "We suggest nevirapine not be used as part of a HAART regimen when HCV RNA replication exists." 3) Diagnosis and Management of Acute Liver Failure [Ссылки доступны только зарегистрированным пользователям ] 
|
|
|
Древовидный вид